Testing for hypertrophic cardiomyopathy is primarily recommended for individuals with a first-degree relative diagnosed with the condition, as well as for people experiencing symptoms like chest pain, ...
Interactive Tool Harnesses Real-World Data to Visualize Burden of Disease in HCM and Advance Equitable Access to Care SOUTH SAN FRANCISCO, Calif., March 20, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, ...
SOUTH SAN FRANCISCO, Calif., March 20, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the launch of EARTH-HCM (Epidemiology, Awareness, Real-world Treatment and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results